Microsatellite abnormalities in plasma of patients with breast carcinoma: Concordance with the primary tumour

Journal of Clinical Pathology

Volumn 52, Issue 5, 1999, Pages 363-366

  Mayall, Frederick ^a   Fairweather, Stefan ^b   Wilkins, Richard ^b   Chang, Bridget ^a   Nicholls, Rebecca ^a  

^a WAIKATO HOSPITAL   (New Zealand)

^b UNIVERSITY OF WAIKATO   (New Zealand)

Author keywords

Breast carcinoma; Microsatellite; Polymerase chain reaction; Tumour markers

Indexed keywords

DNA FRAGMENT; MICROSATELLITE DNA; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EMBEDDING; GENE AMPLIFICATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE; MICROSATELLITE INSTABILITY; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0000049982     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.5.363     Document Type: Article

References (19)

1. 1 Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-50.
2. 2 Mulcahy H, Croke D, Farthing M. Cancer and mutant DNA in blood plasma. Lancet 1996;348:628.
3. 3 Stroun M, Anker P, Lyautey J, et al. Isolation and characterisation of DNA from the plasma of cancer patients. Eur J Clin Oncol 1987;23:707-12.
4. 4 Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989;46:318-22.
5. 5 Fournié GJ, Courtin JP, Laval F, et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995;91:221-77.
6. 6 Vasioukhin V, Anker P, Maurice P, et al. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 1994;86:774-9.
7. 7 Chen XQ, Stroun M, Magnenat J, et al. Microsatellite alterations in serum DNA of small cell lung cancer patients. Nature Med 1996;2:1033-5.
8. 8 Nawroz H, Koch W, Anker P, et al. Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med 1996;2:1035-7.
9. 9 Anker P, Lefort F, Vasioukhin V, et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997;112:1114-20.
10. 10 Mayall F, Jacobson G, Wilkins R, et al. p53 gene mutations can be detected in the plasma of patients with large bowel carcinoma. J Clin Pathol 1998;51:611-13.
11. 11 Gemmell N, Akiyama S. An efficient method for the extraction of DNA from vertebrate tissues. Trends Genet 1996;12:338-9.
12. 12 Yang X, Russo I, Huang Y, et al. Microsatellite instability of D17S513 on chromosome 17 is associated with the progression of breast cancer. Int J Oncol 1997;11:41-6.
13. 13 Chen XQ, Stroun M, Magnenat J, et al. Microsatellite alterations in serum DNA of small cell lung cancer patients. Nature Med 1996;2:1033-5.
14. 14 Nawroz H, Koch W, Anker P, et al. Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med 1996;2:1035-7.
15. 15 Paulson TG, Wright FA, Parker BA, et al. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 1996;56:4021-6.
16. 16 Rosenberg C, de las Morenas A, Huang K, et al. Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. J Clin Invest 1996;98:1095-100.
17. 17 Yee C, Roodi N, Verrier C, et al. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 1994;54:1641-4.
18. 18 Mao L, Lee D, Tockman M, et al. Microsatellite alterations as clonal markers for the detection of cancer. Proc Natl Acad Sci USA 1994;91:9871-5.
19. 19 Dillon EK, de Boer WB, Papadimitriou JM, et al. Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors. Br J Cancer 1997;76:156-62.